American drugmaker Pfizer announced a deal on Monday to acquire Global Blood Therapeutics, makers of a recently approved treatment for sickle cell disease, for $5.4 billion.
People with disability and their caregivers experienced profound impact and systemic neglect during and after the 2017 Northern Rivers floods, with many still unable to access […]
A collaborative study conducted by the UPV/EHU’s Gogo Elebiduna group examined the spontaneous looking patterns of seven-month-old babies when presented with mosaic-like sequences with a symmetrical […]
A revised approach to how emergency services respond to patients in motor vehicle collisions (MVCs) could help to save lives, according to new research.